MedPath
HSA Approval

CLEANXATE TAB 200 mg

SIN09677P

CLEANXATE TAB 200 mg

CLEANXATE TAB 200 mg

March 19, 1998

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Therapeutic

Prescription Only

Formulation Information

TABLET, SUGAR COATED

**Dosage and Administration** Adults (including the elderly) : 1 tablet 3 times daily.

ORAL

Medical Information

**Indications** Symptomatic relief of dysuria, urgency, nocturia, vesical suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis and urethrotrigonitis.

**Contraindications** Patients who have any of the following obstructive conditions : Pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal haemorrhage and obstructive uropathies of the lower urinary tract.

G04BD02

flavoxate

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SAM CHUN DANG PHARM CO LTD

Active Ingredients

FLAVOXATE HCl

200 mg

Flavoxate

Documents

Package Inserts

1.4.3 SIN Cleanxate tab. insert_211103 Clean.pdf

Approved: January 19, 2022

Download
© Copyright 2025. All Rights Reserved by MedPath
CLEANXATE TAB 200 mg - HSA Approval | MedPath